
Retatrutide
Supports research into multi-receptor metabolic signaling and energy balance.
$100.00 CAD

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for its effects on glucose regulation, appetite signaling, and metabolic control. Researchers use it to examine how dual incretin activity influences energy balance and body-composition pathways in laboratory models.